Get started
STRIDES PHARMA SCI LTDSTRIDES PHARMA SCI LTDSTRIDES PHARMA SCI LTD

STRIDES PHARMA SCI LTD

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

STAR trade ideas

STAR aim for the range 697 to 740Looking at the analysis of **STAR (NSE:STAR)** in the following time frames: **22-day time frame**, **weekly time frame**, **daily time frame**, and **4-hour time frame**. The trend suggests a potential movement between the **Support Zone (₹690-₹697)** and the **Resistance Zone (₹740-₹750)**. This translates to a percentage move of approximately **7.42%** 📊. Anything below ₹690 can be considered as a stop loss in this scenario. We are using channel patterns to identify these ranges accurately. The price is currently consolidating near the support range with a potential bullish reversal. **Bullish View:** Expecting a breakout above ₹750, leading to further upward momentum. **Bearish View:** Further decline if the support zone ₹690-₹697 breaks. The setup shows a very interesting formation with high potential! 🚀 ⚠️ **Note:** We should expect further decline if **STAR** breaks the **Support Zone (₹690-₹697)**. ⚠️ 🔔 **Be sure to follow the updated ideas.** 🔔 ⏰ **STAR Analysis** on multiple timeframes! Do not forget to put **Stop Loss** for your positions (for every position you want to open). **Please follow your strategy; this is just my idea, and I will gladly see your ideas in this post.** ✅ **Please do not forget the 'Like' button** add comments ✅ 🙏😊 & Share it with your friends; thanks, and Trade safe. You may refer to my ideas, minds, scripts, and other details here: www.tradingview.com ** NSE:STAR ** **Idea snapshot link:**
NSE:STARLong
by MarxBabu
Analysis of Strides Pharma (NSE: STAR) - 30-Minute TimeframeHead and Shoulders Pattern: The chart shows a completed head and shoulders pattern, which is typically a bearish reversal pattern indicating a potential decline after an uptrend. The pattern has been completed with the left shoulder, head, and right shoulder visible, followed by a drop confirming the neckline break. Double Bottom Formation: Below the head and shoulders pattern, there is a double bottom pattern (labeled as "Bottom 1" and "Bottom 2"). This pattern suggests that after the decline, the stock found support around the ₹1,450 level and began to rise, indicating a potential reversal from bearish to bullish. The breakout above the neckline of the double bottom is an early bullish signal. Bullish Flag: Currently, the stock is forming a bullish flag pattern, which often suggests continuation after an initial uptrend. This is a consolidation phase before a possible breakout to higher levels. The breakout from this flag could target higher levels around ₹1,600-₹1,650 as marked on the chart. Targets: Short-term Target: If the stock breaks out of the bullish flag, the immediate target is around ₹1,600. Extended Target: With sustained momentum, further targets could be around ₹1,650 and ultimately ₹1,725. Support and Resistance: Support Levels: ₹1,500 acts as an immediate support level. Resistance Levels: The primary resistance is around ₹1,600, with further resistance at ₹1,650. Volume Analysis: Volume analysis indicates a notable increase during the breakout from the double bottom, confirming buying interest. Watch for volume spikes accompanying any breakout from the bullish flag for confirmation. Fundamental Analysis of Strides Pharma Company Overview: Strides Pharma is a prominent player in the pharmaceutical industry, focusing on the development and manufacturing of generics and complex products. The company has a strong presence in regulated markets, including the U.S., Europe, and Australia. Revenue and Earnings: The company has shown steady revenue growth, supported by new product launches and expanding market share. However, earnings can be volatile due to pricing pressures in the U.S. generics market and regulatory changes. Recent quarters have shown signs of recovery in margins due to cost optimization and new high-margin product launches. R&D and Product Pipeline: Strides Pharma invests significantly in research and development, focusing on niche and complex generics that offer competitive advantages and higher margins. This focus positions the company well for future growth in both established and emerging markets. Financial Health: The company maintains a balanced debt-to-equity ratio, but investors should monitor any increase in debt levels, especially for capital expenditure and expansion. Positive cash flow trends in recent quarters have strengthened its financial position, aiding in further R&D investments and market expansion. Sector Outlook: The pharmaceutical sector has strong tailwinds with growing global demand for generic drugs, especially in emerging markets. Strides Pharma, with its broad portfolio and strategic focus, is well-placed to benefit from these trends. Conclusion: Technical Outlook: Strides Pharma is showing a bullish setup with a completed double bottom and a current bullish flag pattern. A breakout from the flag could lead to targets at ₹1,600 and potentially ₹1,725 if the momentum continues. Fundamental Outlook: The company has solid fundamentals, supported by its strategic focus on complex generics and a growing product pipeline. While revenue growth is steady, investors should be aware of market-specific risks such as regulatory challenges.
NSE:STARLong
by TheWealthyInvestorbyDSAB
STRIDES PHARMA SCI LTD S/RSupport and Resistance Levels: Support Levels: These are price points (green line/shade) where a downward trend may be halted due to a concentration of buying interest. Imagine them as a safety net where buyers step in, preventing further decline. Resistance Levels: Conversely, resistance levels (red line/shade) are where upward trends might stall due to increased selling interest. They act like a ceiling where sellers come in to push prices down. Breakouts: Bullish Breakout: When the price moves above resistance, it often indicates strong buying interest and the potential for a continued uptrend. Traders may view this as a signal to buy or hold. Bearish Breakout: When the price falls below support, it can signal strong selling interest and the potential for a continued downtrend. Traders might see this as a cue to sell or avoid buying. 20 EMA (Exponential Moving Average): Above 20 EMA(50 EMA): If the stock price is above the 20 EMA, it suggests a potential uptrend or bullish momentum. Below 20 EMA: If the stock price is below the 20 EMA, it indicates a potential downtrend or bearish momentum. Trendline: A trendline is a straight line drawn on a chart to represent the general direction of a data point set. Uptrend Line: Drawn by connecting the lows in an upward trend. Indicates that the price is moving higher over time. Acts as a support level, where prices tend to bounce upward. Downtrend Line: Drawn by connecting the highs in a downward trend. Indicates that the price is moving lower over time. It acts as a resistance level, where prices tend to drop. RSI: RSI readings greater than the 70 level are overbought territory, and RSI readings lower than the 30 level are considered oversold territory. Combining RSI with Support and Resistance: Support Level: This is a price level where a stock tends to find buying interest, preventing it from falling further. If RSI is showing an oversold condition (below 30) and the price is near or at a strong support level, it could be a good buy signal. Resistance Level: This is a price level where a stock tends to find selling interest, preventing it from rising further. If RSI is showing an overbought condition (above 70) and the price is near or at a strong resistance level, it could be a signal to sell or short the asset. Disclaimer: I am not a SEBI registered. The information provided here is for learning purposes only and should not be interpreted as financial advice. Consider the broader market context and consult with a qualified financial advisor before making investment decisions.
NSE:STAR
by zenthosh
Strides Pharma Science Ltd. | Momentum Play | Technical AnalysisStrides Pharma Science Ltd. has been in a loss-making phase for the past four years, with losses gradually decreasing since 2021. However, the stock has shown a remarkable upward rally since March 2023, closely following the 20 EMA (Exponential Moving Average). This stock is purely driven by technical momentum rather than strong fundamentals, making it a higher-risk trade. The consistent rally and adherence to the 20 EMA make it an attractive opportunity for short-term momentum traders. I recommend waiting for confirmation of support before entering. My strategy involves making entries after a long sideways consolidation, followed by a minimum of three bounces off the 20 EMA line, which signals sustained momentum. Avoid entering due to FOMO (Fear of Missing Out). If the current rally is too advanced, it’s better to look for other opportunities where the rally is just building up and offering better entry points. Caution: Since this stock lacks fundamental strength, strict risk management is crucial.
NSE:STAR
by chartedge_learn
Strides pharma LONG for 100% gainChart is self explanatory. Please follow the price action & take the trade as per your appetite. The information provided here is only for educational purpose. The information provided here is not intended to be any kind of financial advice, investment advice, and trading advice. Investment in stock market is very risky and trading stocks, options and other securities involve risk. The risk of loss in stock market can be substantial. Moreover, I am not a SEBI registered analyst, so before taking any decision or before investing in any Share consult your financial advisor and also do your analysis and research. Request your support and engagement by liking and commenting & follow to provide encouragement.
NSE:STARLong
by VivekUshaRastogii
STAR - Wait for the confirmation Expecting a breakout at the level of 357-360 These are my thoughts am not recommended advisor.. Do your own analysis , when you enter , please be prepared with minimum 3-4 good reasons why you enter. * Giving confirmation but failing to breakout * Lets wait for confirmation and make conclusions from MA and VOL * Falling Wedge followed by good consolidatory support zone PS: This is for educational purpose. Feel free to give your own thoughts and I am happy to learn from you.
NSE:STARLong
by imThiyagarajan
2